We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

130 hedge funds and large institutions have $44M invested in Asensus Surgical, Inc. in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 36

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 141130 (-11)

43% less call options, than puts

Call options by funds: $552K | Put options by funds: $967K

48% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 23

52% less capital invested

Capital invested by funds: $92.5M → $44M (-$48.4M)

Holders
130
Holders Change
-11
Holders Change %
-7.8%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
41
Reduced
36
Closed
23
Calls
$552K
Puts
$967K
Net Calls
-$415K
Net Calls Change
+$674K

ASXC Hedge Fund Activity: Q3 2019 in Review

130 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2019, worth a combined $44M — down 52% from $92.5M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ASXC and 12 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 41 added.

The largest buyer was Luminus Management, opening a new position worth an estimated $2.38M. The largest seller was JP Morgan Chase, cutting an estimated $1.86M.

  • 130 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q3 2019, down from 141 in Q2 2019.
  • Funds reported $44M of Asensus Surgical, Inc. stock for Q3 2019, down 52% quarter-over-quarter.
  • 12 funds opened new Asensus Surgical, Inc. positions in Q3 2019 and 23 closed out, a net change of -11 holders.
  • The largest Asensus Surgical, Inc. buyer in Q3 2019 was Luminus Management, an estimated $2.38M added.
  • The largest Asensus Surgical, Inc. seller in Q3 2019 was JP Morgan Chase, an estimated $1.86M sold.

Based on aggregated 13F filings for Q3 2019.